Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02783716 · ClinicalTrials.gov registry record · NA
Vascular Endothelial Function and Cardiac Resynchronization Response in Patients With Heart Failure
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT02783716: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT02783716 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02783716, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine the role of blood vessel endothelial function in heart failure and the effect of Cardiac Resynchronization Therapy (CRT) on heart and endothelial function.
Primary Outcome
Vascular endothelial function will be measured using peripheral arterial tonometry as the reactive hyperemia index (RHI) at baseline and at 3 months.
Interventions
- PROCEDURE Subcutaneous adipose tissue collection
- DIAGNOSTIC_TEST Peripheral arterial tonometry (PAT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-05 |
| Est. Completion | 2021-07-20 |
| Phase | NA |
Why NCT02783716 stopped before completion
NCT02783716 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Subcutaneous adipose tissue collection is the first listed.
NCT02783716 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02783716 about?
NCT02783716 is a clinical study titled "Vascular Endothelial Function and Cardiac Resynchronization Response in Patients With Heart Failure". The purpose of this research study is to determine the role of blood vessel endothelial function in heart failure and the effect of Cardiac Resynchronization Therapy (CRT) on heart and endothelial function.
What is the current status of trial NCT02783716?
This trial is currently terminated. It is a NA study. The enrollment target is 45 participants. The study started on 2016-05. Estimated completion is 2021-07-20.
What interventions are being tested in trial NCT02783716?
The interventions under investigation include: Subcutaneous adipose tissue collection (PROCEDURE), Peripheral arterial tonometry (PAT) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02783716?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02783716's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia